logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
20/12/2025
Morgan Stanley is a popular candidate institution for the first public offering of a company involved in space exploration technology.
Latest
3 m ago
According to CBS: The Epstein documents are expected to be released around 3 PM Eastern Time.
4 m ago
Federal Reserve Governor Milan: Inflation is moving in the right direction and core inflation is lagging behind rent inflation.
4 m ago
Gene Tech: Announces agreement with the US government, specific terms of the agreement are still confidential. The government will exclude Gene Tech's product portfolio from tariff range. The flu drug product line will be supplied through the TrumpRX.gov website, and can also be obtained through the company's recently launched direct-to-patient program. Gene Tech announces a $50 billion investment in US manufacturing.
5 m ago
Novartis Pharmaceuticals: Expected to receive a three-year tariff exemption.
5 m ago
Gilead: Reached agreement with the U.S. government to lower drug costs.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.